Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$693M |
| 2 |
Constellation Brands
STZ
|
+$368M |
| 3 |
Tesla
TSLA
|
+$332M |
| 4 |
NVIDIA
NVDA
|
+$300M |
| 5 |
Booking.com
BKNG
|
+$251M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charter Communications
CHTR
|
+$821M |
| 2 |
Netflix
NFLX
|
+$777M |
| 3 |
AbbVie
ABBV
|
+$583M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$477M |
| 5 |
FedEx
FDX
|
+$456M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.07% |
| 2 | Consumer Discretionary | 17.72% |
| 3 | Financials | 13.25% |
| 4 | Healthcare | 11.94% |
| 5 | Communication Services | 11.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Honeywell
HON
$76.7B
| $9.31M | 0.01% |
71,530
-150,601
| -68% | -$20M |
|
477
Atlantic Union Bankshares
AUB
$6B
| $9.18M | 0.01% |
236,134
+213,699
| +953% | +$8.42M |
|
478
Savara
SVRA
$1.14B
| $8.99M | 0.01% |
794,234
+10,612
| +1% | +$106K |
|
479
Hudbay
HBM
$10.1B
| $8.94M | 0.01% |
+1,602,922
| New | +$10.9M |
|
|
BPL
480
DELISTED
Buckeye Partners, L.P.
BPL
| $8.93M | 0.01% |
254,113
-2,513
| -1% | -$95.9K |
|
481
Heron Therapeutics
HRTX
$94.1M
| $8.74M | 0.01% |
+225,000
| New | +$7.16M |
|
|
REVG
482
DELISTED
REV Group
REVG
| $8.67M | 0.01% |
509,537
+29,121
| +6% | +$516K |
|
483
Neuronetics
STIM
$137M
| $8.64M | 0.01% |
+324,775
| New | +$8.83M |
|
|
CWEN.A
484
DELISTED
Clearway Energy Class A
CWEN.A
| $8.64M | 0.01% |
506,606
| – | – |
|
485
Heritage Financial
HFWA
$1.21B
| $8.47M | 0.01% |
+243,160
| New | +$7.79M |
|
|
SEI
486
Solaris Energy Infrastructure
SEI
$3.14B
| $8.33M | 0.01% |
583,088
-56,130
| -9% | -$932K |
|
487
iShares Russell 1000 Growth ETF
IWF
$120B
| $8.3M | 0.01% |
230,816
-1,452,712
| -86% | -$51.3M |
|
488
Kosmos Energy
KOS
$1.52B
| $8.28M | 0.01% |
1,001,055
+165,488
| +20% | +$1.21M |
|
489
NCS Multistage Holdings
NCSM
$119M
| $8.28M | 0.01% |
28,480
+3,371
| +13% | +$1.07M |
|
|
FTSI
490
DELISTED
FTS International, Inc. Common Stock
FTSI
| $8.21M | 0.01% |
28,814
-5,629
| -16% | -$2.06M |
|
491
Kinross Gold
KGC
$28.2B
| $8.18M | 0.01% |
2,175,230
+487,016
| +29% | +$1.83M |
|
|
RDC
492
DELISTED
Rowan Companies Plc
RDC
| $8.06M | 0.01% |
+496,828
| New | +$7.46M |
|
493
Eastman Chemical
EMN
$8.01B
| $7.43M | 0.01% |
74,289
-34,591
| -32% | -$3.65M |
|
|
ICD
494
DELISTED
Independence Contract Drilling, Inc.
ICD
| $7.25M | 0.01% |
87,970
+7
| +0% | +$601 |
|
|
ENLC
495
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $7.2M | 0.01% |
437,670
-4,641
| -1% | -$74K |
|
496
Littelfuse
LFUS
$11.2B
| $7.16M | 0.01% |
31,376
+445
| +1% | +$95.5K |
|
|
ENLK
497
DELISTED
EnLink Midstream Partners, LP
ENLK
| $6.73M | 0.01% |
433,082
-5,448
| -1% | -$84.2K |
|
|
LBC
498
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $6.4M | 0.01% |
556,068
+9,922
| +2% | +$122K |
|
499
USA Compression Partners
USAC
$3.79B
| $6.21M | 0.01% |
368,938
-2,249
| -0.6% | -$40.2K |
|
500
Enbridge
ENB
$121B
| $6.12M | 0.01% |
+171,187
| New | +$5.42M |
|
Similar funds
Jennison Associates's Q2 2018 Portfolio in Review
As of Q2 2018, Jennison Associates held 740 positions worth $103B, up 2% from $101B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Jennison Associates withdrew a net $3.95B in Q2 2018, closing 87 positions and reducing 296 holdings. Its most notable exit was Great Plains Energy Incorporated, an estimated $152M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Jennison Associates opened a new position in AstraZeneca worth $677M.
- Jennison Associates's largest Q2 2018 buy was AstraZeneca: 9,637,084 shares worth $677M.
- Jennison Associates added most to Constellation Brands in Q2 2018, an estimated $368M increase.
- Jennison Associates's biggest Q2 2018 reduction was Charter Communications, cutting an estimated $821M.
- Jennison Associates fully exited Great Plains Energy Incorporated in Q2 2018, selling an estimated $152M.
- Jennison Associates's ten largest holdings make up 29% of its $103B portfolio in Q2 2018.
- Jennison Associates opened 89 new positions and closed 87 in Q2 2018.
- Jennison Associates's portfolio value rose 2% quarter-over-quarter to $103B.
Based on Jennison Associates's 13F filing for Q2 2018, filed 2 Aug 2018.